Analysts Reaffirm Neutral Rating for BAT Stock

BAT by 2FIRSTS.ai

Dec.18.2023

Analysts Reaffirm Neutral Rating for BAT Stock

JPMorgan Chase & Co. reaffirms neutral rating on British American Tobacco stock, with a target price of £27.

According to a report from MarketBeat, JPMorgan Chase & Co., the multinational investment bank, has reiterated its neutral rating for British American Tobacco stock. They have set a target price of £27 (approximately $33.89) for the stock.

Other research analysts have also recently issued research reports on the company. Royal Bank of Canada has reconfirmed its industry performance rating for British American Tobacco stocks and set a price target of £35 (approximately $43.94) in its research report on November 24th.

Jefferies Financial Group has once again issued a buy rating and set a price target of £41 (approximately $51.47) in their research report on November 15th.

References:

[1] JPMorgan Chase & Co. Reiterates Neutral Rating for British American Tobacco (LON:BATS)

Also Read:

[1] BAT Considers Reducing Stake in Indian Company ITC

[2] JPMorgan lowers stock price target for British American Tobacco.

[3] Mysterious Billionaire Kenneth Dart Increases Stake in BAT

#Europe #Traditional tobacco #United Kingdom #British American Tobacco (BAT)

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. Company TPB Q3 Earnings: Nicotine Pouch Sales Surge 628% YoY, First U.S. Production Line Planned

Turning Point Brands (NYSE: TPB) released its financial results for the third quarter of 2025, reporting strong revenue and profit growth driven by surging Modern Oral (nicotine pouch) sales. The company announced plans to establish its first U.S.-based white pouch production line in 2026, marking a key step toward manufacturing localization.

Nov.06 by 2FIRSTS.ai

WHO's First Global E-Cigarette Data: Over 100 Million Users, Youth Risk 9 Times Higher

The WHO's first global estimate on October 6 showed over 100 million people use e-cigarettes, including at least 15 million adolescents (aged 13–15). The report warned that in reporting countries, children are nine times more likely to vape than adults.

Oct.07 by 2FIRSTS.ai

Harm Reduction Experts Warn: FCTC COP11 Policies Risk Marginalizing the Global South

Two global tobacco harm reduction experts, in their submission to 2Firsts, argue that several COP11 policy proposals driven by high-income countries do not align with the capacities and conditions of low- and middle-income countries. They highlight research and funding gaps and call for a more equitable global support mechanism.

Nov.19

Global Tobacco Oversupply and Climate Risks Highlighted at ITGA Annual Meeting

In 2025, global tobacco leaf production surged, but prices stagnated as climate change intensified farming risks. 2Firsts reports from the ITGA meeting, revealing structural challenges and transition pressures in the industry.